Outset Medical to Present at BofA Home Care Conference
- None.
- None.
The panel discussion will include Leslie Trigg, Outset’s Chair and Chief Executive Officer, Michael Aragon, MD, Outset’s Chief Medical Officer, a home healthcare provider, and a patient currently dialyzing at home with the Tablo® Hemodialysis System. The discussion will focus on home hemodialysis and managing end-stage renal disease.
A live and archived webcast of the discussion will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231129364484/en/
Jim Mazzola
Vice President, Investor Relations
jmazzola@outsetmedical.com
Source: Outset Medical, Inc.
FAQ
What is the latest announcement from Outset Medical, Inc. (OM)?
When and where will the virtual panel discussion take place?
Who will be participating in the panel discussion?
What will be the focus of the panel discussion?
Where can the webcast of the discussion be accessed?
